Patient Guide: A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135), Daratumumab, Lenalidomide or Elranatamab and Lenalidomide Compared With Daratumumab, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 76 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05623020
Status: 🟢 Enrolling Now
Condition: Multiple Myeloma
Phase: PHASE3

Where You Can Participate

This study is available at 76 locations across the country.

Top locations include:
  • • Benowa, Queensland
  • • Fitzroy, Victoria
  • • Melbourne, Victoria
  • • And 73 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135), Daratumumab, Lenalidomide or Elranatamab and Lenalidomide Compared With Daratumumab, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant - Join Clinical Trial NCTNCT05623020

How to Join This Clinical Trial - NCTNCT05623020

Learn how to participate in this PHASE3 trial studying an investigational therapy for Multiple Myeloma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Multiple Myeloma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Multiple Myeloma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05623020 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 76 locations. Find a study site near you:

Clinical Research Site

Benowa, Queensland 4217 - Australia

Status: RECRUITING

Clinical Research Site

Fitzroy, Victoria 3065 - Australia

Status: RECRUITING

Clinical Research Site

Melbourne, Victoria 3002 - Australia

Status: RECRUITING

Clinical Research Site

Melbourne, Victoria 3004 - Australia

Status: RECRUITING

Clinical Research Site

Halifax, Nova Scotia B3H 2Y9 - Canada

Status: RECRUITING

Clinical Research Site

Halifax, Nova Scotia B3S 0H6 - Canada

Status: RECRUITING

Clinical Research Site

Toronto, Ontario M5G 2M9 - Canada

Status: RECRUITING

Clinical Research Site

Guangzhou, Guangdong 510515 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Suzhou, Jiangsu 215006 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Tianjin, Tianjin Municipality 300020 - China

Status: RECRUITING

And 66 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Multiple Myeloma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships